{"cik":1832038,"entityName":"Adagio Therapeutics, Inc.","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2021-09-13","val":111251660,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q3I"},{"end":"2021-11-08","val":111251660,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}}},"us-gaap":{"AccountsPayableCurrent":{"label":"Accounts Payable, Current","description":"Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":8153000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":8153000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":10716000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":17564000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AccruedEmployeeBenefitsCurrent":{"label":"Accrued Employee Benefits, Current","description":"Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":794000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":794000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":1272000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":2575000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AccruedLiabilitiesCurrent":{"label":"Accrued Liabilities, Current","description":"Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":4919000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":4919000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":27181000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":35485000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AccruedLiabilitiesCurrentAndNoncurrent":{"label":"Accrued Liabilities","description":"Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.","units":{"USD":[{"end":"2020-12-31","val":4919000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":4919000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":27181000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":35485000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AccruedProfessionalFeesCurrentAndNoncurrent":{"label":"Accrued Professional Fees","description":"Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.","units":{"USD":[{"end":"2020-12-31","val":237000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":237000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":2262000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":2239000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AdditionalPaidInCapitalCommonStock":{"label":"Additional Paid in Capital, Common Stock","description":"Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.","units":{"USD":[{"end":"2020-12-31","val":154000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":154000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":4067000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":842272000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue":{"label":"APIC, Share-based Payment Arrangement, Increase for Cost Recognition","description":"Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":7000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-03-31","val":587000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-01-01","end":"2021-03-31","val":587000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q1"},{"start":"2021-04-01","end":"2021-06-30","val":3342000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":3342000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q2"},{"start":"2021-07-01","end":"2021-09-30","val":5979000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"AllocatedShareBasedCompensationExpense":{"label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","units":{"USD":[{"start":"2020-06-03","end":"2020-06-30","val":0,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2020Q2I"},{"start":"2020-06-03","end":"2020-09-30","val":7000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":7000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":3929000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":3342000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":9908000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":5979000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":{"label":"Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount","description":"Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.","units":{"shares":[{"start":"2020-06-03","end":"2020-06-30","val":5593240,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2020Q2I"},{"start":"2020-06-03","end":"2020-09-30","val":66098810,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":103848980,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":103848980,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":21320100,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":21320100,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":117382000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":117382000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":397992000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":686270000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AssetsCurrent":{"label":"Assets, Current","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":117382000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":117382000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":396059000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":680155000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2020-12-31","val":114988000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":114988000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":392509000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":478269000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents","description":"Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"end":"2020-06-02","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q2I"},{"end":"2020-09-30","val":48577000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3I"},{"end":"2020-12-31","val":114988000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":114988000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":392509000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":478269000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect","description":"Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":48577000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":277521000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-01-01","end":"2021-09-30","val":363281000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD/shares":[{"end":"2020-12-31","val":0.0001,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":0.0001,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":0.0001,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":0.0001,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CommonStockSharesAuthorized":{"label":"Common Stock, Shares Authorized","description":"The maximum number of common shares permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-31","val":150000000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":150000000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":150000000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-07-30","val":150000000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"end":"2021-09-30","val":1000000000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2020-12-31","val":28193240,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":28193240,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":5599240,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-07-30","val":150000000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"end":"2021-09-30","val":111251660,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CommonStockSharesOutstanding":{"label":"Common Stock, Shares, Outstanding","description":"Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.","units":{"shares":[{"end":"2020-12-31","val":5593240,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":5593240,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":5599240,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":111251660,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CommonStockValue":{"label":"Common Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2020-12-31","val":1000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":1000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":1000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":5000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue":{"label":"Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value","description":"Value of outstanding nonredeemable convertible preferred stock or outstanding convertible preferred stock that is redeemable solely at the option of the issuer.","units":{"USD":[{"end":"2020-12-31","val":169548000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":169548000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":504711000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ConvertiblePreferredStockSharesIssuedUponConversion":{"label":"Convertible Preferred Stock, Shares Issued upon Conversion","description":"Number of shares issued for each share of convertible preferred stock that is converted.","units":{"shares":[{"end":"2020-12-31","val":63239670,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":63239670,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":84722420,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"}]}},"CostsAndExpensesRelatedParty":{"label":"Costs and Expenses, Related Party","description":"Costs of sales and operating expenses for the period incurred from transactions with related parties.","units":{"USD":[{"start":"2020-06-03","end":"2020-06-30","val":0,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2020Q2I"},{"start":"2020-06-03","end":"2020-09-30","val":291000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":291000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":435000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":247000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":2261000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":1826000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized":{"label":"Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount","description":"Amount of cost not yet recognized for nonvested award under share-based payment arrangement.","units":{"USD":[{"end":"2021-06-30","val":69600000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":86700000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare":{"label":"Income (Loss) from Continuing Operations, Per Basic and Diluted Share","description":"The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.","units":{"USD/shares":[{"start":"2020-06-03","end":"2020-09-30","val":-7.55,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":-25.98,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":-0.66,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":-0.18,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":-7.06,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":-0.98,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"IncomeTaxExpenseBenefit":{"label":"Income Tax Expense (Benefit)","description":"Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.","units":{"USD":[{"start":"2020-06-03","end":"2020-06-30","val":0,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2020Q2I"},{"start":"2020-06-03","end":"2020-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":0,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":0,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"IncreaseDecreaseInAccountsPayable":{"label":"Increase (Decrease) in Accounts Payable","description":"The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.","units":{"USD":[{"start":"2020-06-03","end":"2020-06-30","val":2000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2020Q2I"},{"start":"2020-06-03","end":"2020-09-30","val":5210000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":2159000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-01-01","end":"2021-09-30","val":8909000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"IncreaseDecreaseInAccruedLiabilities":{"label":"Increase (Decrease) in Accrued Liabilities","description":"The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.","units":{"USD":[{"start":"2020-06-03","end":"2020-06-30","val":96000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2020Q2I"},{"start":"2020-06-03","end":"2020-09-30","val":1881000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":21054000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-01-01","end":"2021-09-30","val":30122000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets":{"label":"Increase (Decrease) in Prepaid Expense and Other Assets","description":"Amount of increase (decrease) in prepaid expenses, and assets classified as other.","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":47000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":1146000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-01-01","end":"2021-09-30","val":11342000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"InvestmentIncomeInterest":{"label":"Investment Income, Interest","description":"Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":32000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":23000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":80000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":48000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"Liabilities":{"label":"Liabilities","description":"Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.","units":{"USD":[{"end":"2020-12-31","val":13083000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":13083000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":37905000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":53057000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2020-12-31","val":117382000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":117382000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":397992000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":686270000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"LiabilitiesCurrent":{"label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":13072000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":13072000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":37897000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":53049000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":49720000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":334832000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-01-01","end":"2021-09-30","val":663432000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":-1143000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":-57311000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-01-01","end":"2021-09-30","val":-111524000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2020-04-01","end":"2020-06-30","val":-98000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q2"},{"start":"2020-06-03","end":"2020-06-30","val":-98000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2020Q2I"},{"start":"2020-06-04","end":"2020-06-30","val":-98000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2020-06-03","end":"2020-09-30","val":-48106000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":-48008000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2020-06-03","end":"2020-12-31","val":-65300000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2020-06-03","end":"2020-12-31","val":-65300000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-03-31","val":-38700000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-01-01","end":"2021-03-31","val":-38700000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q1"},{"start":"2021-01-01","end":"2021-06-30","val":-83373000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":-44673000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":-44673000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":-143748000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":-60375000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"NonoperatingIncomeExpense":{"label":"Nonoperating Income (Expense)","description":"The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":26000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":18000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":70000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":43000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"OperatingExpenses":{"label":"Operating Expenses","description":"Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.","units":{"USD":[{"start":"2020-06-03","end":"2020-06-30","val":98000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2020Q2I"},{"start":"2020-06-03","end":"2020-09-30","val":48106000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":48008000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":83399000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":44691000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":143818000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":60418000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"OperatingIncomeLoss":{"label":"Operating Income (Loss)","description":"The net result for the period of deducting operating expenses from operating revenues.","units":{"USD":[{"start":"2020-06-03","end":"2020-06-30","val":-98000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2020Q2I"},{"start":"2020-06-03","end":"2020-09-30","val":-48106000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":-48008000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":-83399000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":-44691000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":-143818000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":-60418000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"OtherAccruedLiabilitiesCurrentAndNoncurrent":{"label":"Other Accrued Liabilities","description":"Amount of expenses incurred but not yet paid classified as other.","units":{"USD":[{"end":"2020-12-31","val":35000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":35000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":4000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":660000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"OtherAssetsCurrent":{"label":"Other Assets, Current","description":"Amount of current assets classified as other.","units":{"USD":[{"end":"2020-12-31","val":63000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":22000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":261000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":579000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"OtherNonoperatingGainsLosses":{"label":"Other Nonoperating Gains (Losses)","description":"Amount of gain (loss) related to nonoperating activities, classified as other.","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":-6000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":-5000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":-10000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":-5000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"PreferredStockLiquidationPreferenceValue":{"label":"Preferred Stock, Liquidation Preference, Value","description":"Value of the difference between preference in liquidation and the par or stated values of the preferred shares.","units":{"USD":[{"end":"2020-12-31","val":169900000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2020Q4I"},{"end":"2021-06-30","val":505399000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"}]}},"PreferredStockSharesAuthorized":{"label":"Preferred Stock, Shares Authorized","description":"The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-31","val":12647934,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":16944484,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":10000000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"PreferredStockSharesIssued":{"label":"Preferred Stock, Shares Issued","description":"Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.","units":{"shares":[{"end":"2020-12-31","val":12647934,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":16944484,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-07-30","val":16944484,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"end":"2021-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"PreferredStockSharesOutstanding":{"label":"Preferred Stock, Shares Outstanding","description":"Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.","units":{"shares":[{"end":"2020-12-31","val":12647934,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":16944484,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"PreferredStockValue":{"label":"Preferred Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2020-12-31","val":169548000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":504711000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"PrepaidExpenseAndOtherAssetsCurrent":{"label":"Prepaid Expense and Other Assets, Current","description":"Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":2394000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":2394000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":3550000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":13833000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ProceedsFromIssuanceOfConvertiblePreferredStock":{"label":"Proceeds from Issuance of Convertible Preferred Stock","description":"The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":49706000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":335264000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-01-01","end":"2021-09-30","val":335163000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ProfitLoss":{"label":"Net Income (Loss), Including Portion Attributable to Noncontrolling Interest","description":"The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.","units":{"USD":[{"start":"2020-06-03","end":"2020-06-30","val":-98000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2020Q2I"},{"start":"2020-06-03","end":"2020-09-30","val":-48106000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":-83373000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-01-01","end":"2021-09-30","val":-143748000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ResearchAndDevelopmentExpense":{"label":"Research and Development Expense","description":"The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.","units":{"USD":[{"start":"2020-06-03","end":"2020-06-30","val":48000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2020Q2I"},{"start":"2020-06-03","end":"2020-09-30","val":7299000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":7251000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":69204000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":35067000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":114465000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":45366000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"RetainedEarningsAccumulatedDeficit":{"label":"Retained Earnings (Accumulated Deficit)","description":"The cumulative amount of the reporting entity's undistributed earnings or deficit.","units":{"USD":[{"end":"2020-12-31","val":-65319000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":-65319000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":-148692000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":-209067000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"RoyaltyExpense":{"label":"Royalty Expense","description":"Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.","units":{"USD":[{"start":"2021-01-01","end":"2021-06-30","val":0,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"SaleOfStockPricePerShare":{"label":"Sale of Stock, Price Per Share","description":"Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.","units":{"USD/shares":[{"end":"2021-06-30","val":8,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":8,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"SellingGeneralAndAdministrativeExpense":{"label":"Selling, General and Administrative Expense","description":"The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.","units":{"USD":[{"start":"2020-06-03","end":"2020-06-30","val":50000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2020Q2I"},{"start":"2020-06-03","end":"2020-09-30","val":892000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":842000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":10695000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":7124000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":21853000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":11052000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"ShareBasedCompensation":{"label":"Share-based Payment Arrangement, Noncash Expense","description":"Amount of noncash expense for share-based payment arrangement.","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":7000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":3929000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-01-01","end":"2021-09-30","val":9908000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period","description":"The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).","units":{"shares":[{"start":"2020-06-03","end":"2020-12-31","val":6943240,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2020-06-03","end":"2020-12-31","val":6943240,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-06-30","val":0,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number","description":"The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.","units":{"shares":[{"end":"2020-12-31","val":5593240,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":5593240,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":4194930,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":3859139,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period","description":"The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.","units":{"shares":[{"start":"2020-06-03","end":"2020-12-31","val":0,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2020-06-03","end":"2020-12-31","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-06-30","val":1398310,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-01-01","end":"2021-09-30","val":1734101,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number","description":"The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.","units":{"shares":[{"end":"2021-06-30","val":92500,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":1025630,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price","description":"The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.","units":{"USD/shares":[{"end":"2021-06-30","val":12.8,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":2.32,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period","description":"The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.","units":{"shares":[{"start":"2021-01-01","end":"2021-06-30","val":115000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-01-01","end":"2021-09-30","val":232187,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross","description":"Gross number of share options (or share units) granted during the period.","units":{"shares":[{"start":"2021-01-01","end":"2021-06-30","val":12078560,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-01-01","end":"2021-09-30","val":14725078,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value","description":"The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.","units":{"USD/shares":[{"start":"2020-06-03","end":"2020-06-30","val":0.01,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2020Q2I"},{"start":"2020-06-03","end":"2020-09-30","val":0.21,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":0.68,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":5.96,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":6.75,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":6.51,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":9.03,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value","description":"Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.","units":{"USD":[{"end":"2020-12-31","val":11362000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":11362000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":77563000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":586814000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number","description":"Number of options outstanding, including both vested and non-vested options.","units":{"shares":[{"end":"2020-12-31","val":2968070,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":2968070,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":14931630,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":17460961,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price","description":"Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.","units":{"USD/shares":[{"end":"2020-12-31","val":0.78,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":0.78,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":7.61,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":8.63,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value","description":"Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.","units":{"USD":[{"end":"2021-06-30","val":77563000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":586814000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number","description":"Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.","units":{"shares":[{"end":"2021-06-30","val":14931630,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":17460961,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price","description":"Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.","units":{"USD/shares":[{"end":"2021-06-30","val":7.61,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":8.63,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price","description":"Weighted average price at which option holders acquired shares when converting their stock options into shares.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-06-30","val":0,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price","description":"Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-06-30","val":4.61,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-01-01","end":"2021-09-30","val":2.68,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price","description":"Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-06-30","val":9.26,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-01-01","end":"2021-09-30","val":10.12,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value","description":"Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.","units":{"USD":[{"end":"2021-06-30","val":0,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":40943000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"StockholdersEquity":{"label":"Stockholders' Equity Attributable to Parent","description":"Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.","units":{"USD":[{"end":"2020-06-30","val":-98000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-06-30","val":-98000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q2I"},{"end":"2020-09-30","val":-48184000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3I"},{"end":"2020-12-31","val":-65249000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":-65249000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-03-31","val":-103362000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2021-03-31","val":-103362000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q1I"},{"end":"2021-06-30","val":-144624000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2021-06-30","val":-144624000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q2I"},{"end":"2021-09-30","val":633213000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"StockIssuedDuringPeriodSharesStockOptionsExercised":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period","description":"Number of share options (or share units) exercised during the current period.","units":{"shares":[{"start":"2021-01-01","end":"2021-06-30","val":0,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"}]}},"StockIssuedDuringPeriodValueNewIssues":{"label":"Stock Issued During Period, Value, New Issues","description":"Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.","units":{"USD":[{"start":"2021-04-01","end":"2021-06-30","val":66000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":66000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q2"}]}},"StockIssuedDuringPeriodValueStockOptionsExercised":{"label":"Stock Issued During Period, Value, Stock Options Exercised","description":"Value of stock issued as a result of the exercise of stock options.","units":{"USD":[{"start":"2021-04-01","end":"2021-06-30","val":3000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":3000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q2"},{"start":"2021-07-01","end":"2021-09-30","val":1000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"TreasuryStockShares":{"label":"Treasury Stock, Shares","description":"Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.","units":{"shares":[{"end":"2020-12-31","val":22600000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":22600000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":0,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"TreasuryStockValue":{"label":"Treasury Stock, Value","description":"The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.","units":{"USD":[{"end":"2020-12-31","val":85000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"end":"2020-12-31","val":85000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":0,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2I"},{"end":"2021-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"WeightedAverageNumberOfShareOutstandingBasicAndDiluted":{"label":"Weighted Average Number of Shares Outstanding, Basic and Diluted","description":"Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).","units":{"shares":[{"start":"2020-06-03","end":"2020-06-30","val":21250000,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2020Q2I"},{"start":"2020-06-03","end":"2020-09-30","val":6375000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":1847826,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":125574,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20"},{"start":"2021-04-01","end":"2021-06-30","val":249769,"accn":"0000950170-21-001832","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-09-20","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":20346771,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":61297086,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"AccretionAmortizationOfDiscountsAndPremiumsInvestments":{"label":"Accretion (Amortization) of Discounts and Premiums, Investments","description":"The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":577000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"AccumulatedOtherComprehensiveIncomeLossNetOfTax":{"label":"Accumulated Other Comprehensive Income (Loss), Net of Tax","description":"Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":3000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AdjustmentForAmortization":{"label":"Amortization","description":"The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":188050000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"AssetsFairValueAdjustment":{"label":"Assets, Fair Value Adjustment","description":"Amount of addition (reduction) to the amount at which an asset could be incurred (settled) in a current transaction between willing parties.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":188053000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue":{"label":"Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value","description":"This item represents the aggregate fair value of investments in debt and equity securities categorized neither as held-to-maturity nor trading securities that have been in a continuous unrealized loss position for twelve months or longer.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CommonStockCapitalSharesReservedForFutureIssuance":{"label":"Common Stock, Capital Shares Reserved for Future Issuance","description":"Aggregate number of common shares reserved for future issuance.","units":{"shares":[{"end":"2021-09-30","val":36417895,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ComprehensiveIncomeNetOfTax":{"label":"Comprehensive Income (Loss), Net of Tax, Attributable to Parent","description":"Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":-48106000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":-48008000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-143745000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":-60372000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments":{"label":"Gain (Loss) on Investments, Excluding Other than Temporary Impairments","description":"This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"IncreaseDecreaseInOtherNoncurrentAssets":{"label":"Increase (Decrease) in Other Noncurrent Assets","description":"Amount of increase (decrease) in noncurrent assets classified as other.","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":-3000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-6016000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"InterestReceivable":{"label":"Interest Receivable","description":"Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":682000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"MarketableSecurities":{"label":"Marketable Securities","description":"Amount of investment in marketable security.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":188053000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"NetCashProvidedByUsedInInvestingActivities":{"label":"Net Cash Provided by (Used in) Investing Activities","description":"Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-188627000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"OperatingLeasesRentExpenseNet":{"label":"Operating Leases, Rent Expense, Net","description":"Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.","units":{"USD":[{"start":"2021-07-01","end":"2021-09-30","val":100000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"OtherAssetsNoncurrent":{"label":"Other Assets, Noncurrent","description":"Amount of noncurrent assets classified as other.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":6115000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent":{"label":"Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent","description":"Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":3000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":3000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"PaymentsToAcquireMarketableSecurities":{"label":"Payments to Acquire Marketable Securities","description":"Amount of cash outflow for purchase of marketable security.","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":188627000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"PreferredStockParOrStatedValuePerShare":{"label":"Preferred Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.","units":{"USD/shares":[{"end":"2020-12-31","val":0.0001,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0.0001,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"PrepaidInsurance":{"label":"Prepaid Insurance","description":"Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":41000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":4558000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ProceedsFromIssuanceOfCommonStock":{"label":"Proceeds from Issuance of Common Stock","description":"The cash inflow from the additional capital contribution to the entity.","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":330905000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock":{"label":"Proceeds from Issuance of Redeemable Convertible Preferred Stock","description":"The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":40000000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ProceedsFromStockOptionsExercised":{"label":"Proceeds from Stock Options Exercised","description":"Amount of cash inflow from exercise of option under share-based payment arrangement.","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":14000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments":{"label":"Realized Gain (Loss) on Marketable Securities, Cost Method Investments, and Other Investments","description":"This item represents the total realized gain (loss) included in earnings for the period as a result of selling marketable securities categorized as trading, available-for-sale, or held-to-maturity and any gains or losses realized during the period from the sale of investments accounted for under the cost method of accounting and/or investments that are separately or otherwise not categorized as trading, available-for-sale, or held-to-maturity. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ResearchAndDevelopmentInProcess":{"label":"Research and Development in Process","description":"The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.","units":{"USD":[{"start":"2020-06-03","end":"2020-09-30","val":39915000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"SaleLeasebackTransactionMonthlyRentalPayments":{"label":"Sale Leaseback Transaction, Monthly Rental Payments","description":"The amount of the monthly rental payments due under the lease entered into in connection with the transactions involving the sale of property to another party and the lease of the property back to the seller.","units":{"USD":[{"end":"2021-09-14","val":400000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities":{"label":"Stock Issued During Period, Value, Conversion of Convertible Securities","description":"The gross value of stock issued during the period upon the conversion of convertible securities.","units":{"USD":[{"start":"2021-07-01","end":"2021-09-30","val":504709000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"StockRepurchasedDuringPeriodValue":{"label":"Stock Repurchased During Period, Value","description":"Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.","units":{"USD":[{"start":"2020-07-01","end":"2020-09-30","val":85000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"}]}},"TemporaryEquityLiquidationPreference":{"label":"Temporary Equity, Liquidation Preference","description":"The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.","units":{"USD":[{"end":"2020-12-31","val":169900000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"}]}},"TemporaryEquitySharesAuthorized":{"label":"Temporary Equity, Shares Authorized","description":"The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.","units":{"shares":[{"end":"2020-12-31","val":12647934,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"}]}},"TemporaryEquitySharesIssued":{"label":"Temporary Equity, Shares Issued","description":"The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.","units":{"shares":[{"end":"2020-12-31","val":12647934,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"}]}},"TemporaryEquitySharesOutstanding":{"label":"Temporary Equity, Shares Outstanding","description":"The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.","units":{"shares":[{"end":"2020-12-31","val":12647934,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"}]}},"UnrealizedGainOnSecurities":{"label":"Unrealized Gain on Securities","description":"The increase (decrease), resulting in a gain, in the difference between the fair value and the carrying value, or in the comparative fair values, of securities held at each balance sheet date, that was included in earnings for the period.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":3000,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"UnrealizedLossOnSecurities":{"label":"Unrealized Loss on Securities","description":"The increase (decrease), resulting in a loss, in the difference between the fair value and the carrying value, or in the comparative fair values, of securities held at each balance sheet date, that was included in earnings for the period.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0000950170-21-004586","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}}}}}